Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells-Reference-Cited by-同舟云学术

Antibody‐dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells

Published:2017-02-21 Issue:4 Volume:95 Page:347-355
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Ochoa Maria Carmen¹²,Minute Luna¹²,Rodriguez Inmaculada¹²³⁴,Garasa Saray¹²,Perez‐Ruiz Elisabeth⁵,Inogés Susana¹³⁴,Melero Ignacio¹²³⁴,Berraondo Pedro¹²³⁴

Affiliation:

1. Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA) Pamplona Spain

2. Navarra Institute for Health Research (IDISNA) Pamplona Spain

3. Servicio de Inmunología e Inmunoterapia, Clínica Universidad de Navarra Pamplona Spain

4. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Spain

5. Department of Medical Oncology (REDISSEC), Hospital Costa del Sol Marbella Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2017.6

Reference95 articles.

1. Oncology Meets Immunology: The Cancer-Immunity Cycle

2. Natural killer cell recognition of missing self

3. Tumor location determines tissue‐specific recruitment of tumor‐associated macrophages and antibody‐dependent immunotherapy response;Lehmann B;Sci Immunol,2017

4. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma

5. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms;International Immunopharmacology;2024-09

2. Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-09

3. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

4. Types of cell death and their relations to host immunological pathways;Aging;2024-08-08

5. Cancer therapy via neoepitope-specific monoclonal antibody cocktails;2024-08-06